2017 MIPS Measure #116: Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis

Valid Data Submission Method(s) Measure Type High Priority Measure? NQS Domain Specialty Measure Sets
Registry Process Yes Efficiency and Cost Reduction Internal Medicine, Emergency Medicine, General Practice/Family Medicine

Measure Description

The percentage of adults 18-64 years of age with a diagnosis of acute bronchitis who were not dispensed an antibiotic prescription

Instruction

This measure is to be reported at each occurrence of acute bronchitis during the performance period. This measure may be reported by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

Denominator

All patients aged 18 through 64 years of age with an outpatient or emergency department (ED) visit with a diagnosis of acute bronchitis during the measurement period

DENOMINATOR NOTE: To determine eligibility, look for any of the listed antibiotic drugs below in the 30 days
prior to the visit with the acute bronchitis diagnosis. As long as there are no prescriptions for the listed
antibiotics during this time period, the patient is eligible for denominator inclusion. Do not include ED visits that
result in an inpatient admission. An ED visit results in an inpatient admission when the ED date of service and
the admission date for the inpatient stay are one calendar day apart or less.

*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee
Schedule (PFS). These non-covered services should be counted in the denominator population for registrybased
measures.

Denominator Criteria (Eligible Cases):
Patients18 through 64 years of age on date of encounter
AND
Diagnosis for acute bronchitis (ICD-10-CM): J20.3, J20.4, J20.5, J20.6, J20.7, J20.8, J20.9
AND
Patient encounter during the performance period (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99217, 99218, 99219, 99220, 99281, 99282, 99283, 99284, 99285, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0402, G0438, G0439, G0463*, T1015*
AND NOT
DENOMINATOR EXCLUSIONS:
ED visits that result in an inpatient admission
OR
Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, Lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/UTI, acne, HIV disease/asymptomatic HIV, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis: G9712
OR
Patients who use hospice services any time during the measurement period: G9713

Numerator

Patients who were not prescribed or dispensed antibiotics on or within 3 days of the initial date of service

Numerator Instructions: For performance, the measure will be calculated as the number of patient
encounters where antibiotics were neither prescribed nor dispensed on or within 3 days of the episode for
acute bronchitis over the total number of encounters in the denominator (patients aged 18 through 64 years
with an outpatient or ED visit for acute bronchitis). A higher score indicates appropriate treatment of patients
with acute bronchitis (e.g., the proportion for whom antibiotics were not prescribed or dispensed on or three
days after the encounter).

Antibiotic Medications

Description                              Prescription                                          

 

Aminoglycosides

Amikacin

Tobramycin Gentamicin

Kanamycin

Streptomycin

Aminopenicillins

Amoxicillin

Ampicillin

Antipseudomonal

penicillins

Piperacillin

 

Beta-lactamase inhibitors

Amoxicillin-

Ampicillin- sulbactam tazobactam

 

Piperacillin

Ticarcillin-clavulanate

First-generation

cephalosporins

Cefadroxil

Cefazolin

Fourth-generation cephalosporins

Cefepime      

 

Ketolides

Telithromycin

 

Lincomycin derivatives

Clindamycin Lincomycin

 

Macrolides

Azithromycin Clarithromycin ethylsuccinate

Erythromycin stearate

ErythromycinErythromycin

Erythromycin lactobionate

Miscellaneous antibiotics

Aztreonam

Chloramphenicol

Vancomycin

Dalfopristin-sulfisoxazole quinupristin Linezolid

Daptomycin

MetronidazoleErythromycin

Description

Prescription

 

 

Natural penicillins

Penicillin G sodium potassium

 

 

Penicillin V potassium benzathine procaine

Penicillinase resistant penicillins

Dicloxacillin Oxacillin

 

Nafcillin

Quinolones

Ciprofloxacin Gemifloxacin

Ofloxacin

 

Levofloxacin

Norfloxacin

Rifamycin derivatives

Rifampin

 

 

Second generation cephalosporin

Cefaclor

Cefotetan Cefprozil

 

Cefoxitin

Cefuroxime

Sulfonamides

Sulfadiazine

 

Sulfamethoxazol e-trimethoprim

Tetracyclines

Doxycycline Tetracycline

 

Minocycline

Third generation cephalosporins

Cefdinir

Cefditoren

Cefpodoxime

 

Cefotaxime

Ceftibuten

Ceftriaxone

Description

Prescription

 

 

Urinary anti-infectives

Fosfomycin

Nitrofurantoin  macrocrystals Trimethoprim

 

Nitrofuantoin

Nitrofurantoin  monohydrate macrocrystals

 

Numerator Options:
Performance Met: Antibiotic neither prescribed nor dispensed (4124F)
OR
Performance Not Met: Antibiotic prescribed or dispensed (4120F)

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.